U.S. High Court Won't Review Puerto Rico's Regulation Of Wholesale Drug Prices

U.S. High Court Won't Review Puerto Rico's Regulation Of Wholesale Drug Prices

WASHINGTON, D.C. - The U.S. Supreme Court on Oct. 7 denied review of a lower court ruling that Puerto Rico can regulate the price of drugs Novartis Pharmaceuticals Corp. sells to wholesalers in that territory (Novartis Pharmaceuticals, Corp., v. Puerto Rico Department of Consumer Affairs, No. 13-77, U.S. Sup.).

Find full version on lexis Advance®
Access this news story on lexis.com®